Publications found:
112,588
Sort by:
Research Report on China's High-end Medical Treatment Industry, 2013-2017
US$ 2,800.00
... are on the rather low level. The rich and foreigners in China attach importance to quality and privacy of medical services and they are ... is easier to create characteristics through equipment, technologies and services, China's high-end medical services are concentrated in these fields. However, investments in ...
December 2012
50 pages
Italy Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities
US$ 2,880.00
... report contains 142 pages, 15 tables and presents a comprehensive analysis of the Italian flow cytometry market, including: Major issues pertaining to the Italian ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
142 pages
Japan Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities
US$ 3,600.00
... report contain 142 pages, 15 tables and presents a comprehensive analysis of the Japanese flow cytometry market, including: Major issues pertaining to the Japanese ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
142 pages
Spain Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities
US$ 2,880.00
... report contains 140 pages, 15 tables and presents a comprehensive analysis of the Spanish flow cytometry market, including: Major issues pertaining to the Spanish ... . Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
140 pages
UK Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities
US$ 2,880.00
This report contains 146 pages, 15 tables and presents a comprehensive analysis of the UK flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
146 pages
US Flow Cytometry Market: Innovative Technologies and Emerging Business Opportunities
US$ 4,720.00
This report contains 147 pages, 17 tables and presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the ... systems. Five-year reagent and instrument sales forecasts. Sales and market shares of leading reagent and instrument suppliers. Review of current and ...
December 2012
147 pages
Tele-Health Carts, Servers, and Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
US$ 3,700.00
WinterGreen Research announces that it has a new study on Tele-Health Carts, Servers, and Monitoring Market Shares and Forecasts, Worldwide, 2012 ... anticipated to grow rapidly worldwide as efficiencies of scale are realized for monitoring and treating people with chronic conditions in a more standardized manner ...
December 2012
366 pages
Competitor Analysis: Toll-like Receptor (TLR) Agonists & Antagonists
US$ 910.00
... description The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small ... with the project data to print or export an individual report. Toll-like receptors (TLRs) are a class of proteins that play a key role ...
December 2012
178 pages
India Cosmetic Surgery Market Outlook 2016
US$ 700.00
... cosmetic surgeries market inIndia. Research report “India Cosmetic Surgery Market Outlook 2016” gives comprehensive overview on the following aspects related to Cosmetic surgery segment in India. Cosmetic surgery Market Potential Treatment Cost Patient Profile & Preferred Cosmetic ...
December 2012
70 pages
U.S. Market for Fetal and Neonatal Monitoring Devices - (Part of Segment Series)
US$ 2,995.00
... Drivers & Limiters Mergers & Acquisitions Customer Feedback and Market Monitoring SubSegments Included: Fetal and neonatal monitoring Invasive and Non-Invasive ... and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The ...
November 2012
65 pages
Global Hearing Instruments Market Report: 2012 Edition
US$ 800.00
... hearing loss. The hearing loss is treated by hearing instruments which include two categories: Hearing Aid and Hearing Implant. The present report offers a comprehensive analysis of the worldwide hearing instrument ... Korea. The competition in the global hearing instrument market is intense with few large players ...
November 2012
53 pages
Advanced Wound Care: World Market Prospects 2013-2023
US$ 2,401.00
... grow steadily to 2023, primarily driven by an increase in the prevalence of chronic wounds including diabetic ulcers and pressure ulcers, approval of innovative devices ... key business opportunities. Why you should buy Advanced Wound Care: World Market Prospects 2013-2023 148 pages of comprehensive analysis ...
November 2012
171 pages
Medicated Skin Care in Romania
US$ 990.00
... , when they generally seek a medical recommendation, the level of self-medication increased rapidly in Bucharest and... Euromonitor International's Medicated Skin Care in Romania report offers a comprehensive guide ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
November 2012
30 pages
Brisotl-Myers Squibb - Eliquis Approved for SPAF in Europe – Waiting for decision with FDA
US$ 90.00
... and PFE announced the long awaited approval of Eliquis for stroke prevention in atrial fibrillation ... US approval, for which the PDUFA data has been set for 17th March 2013. . We foresee Eliquis clearly ... demonstrated in the ROCKET-AF trial. We expect Eliquis to cannibalize Pradaxa sales initially, while extensive ...
November 2012
2 pages
NATCO PHARMA– Outperform, Great Result - More to Come
US$ 140.00
Natco Pharma’s Q2 FY13 result was much ahead of our expectation on sales and EBITDA largely ... our expectation as Natco wrote off `61m as payment to SMS pharma over its old litigation. The company already launched Sunitinib in India, however, expects ...
November 2012
8 pages
Top 100 Dental Practices (Denmark)
US$ 1,250.00
This report is an in-depth financial evaluation of the Denmark Dental Practices. Using the unique Plimsoll method of analysis, each of the largest 100 companies is individually assessed and ranked against each other and compared to industry averages.Using the most ...
November 2012
205 pages
Medicated Skin Care in Saudi Arabia
US$ 990.00
... /pharmacies and female pharmacists. Private consulting rooms at... Euromonitor International's Medicated Skin Care in Saudi Arabia report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
November 2012
30 pages
Celgene - ABRAXANE + Pipeline Drugs = Long Term Growth!
US$ 140.00
... Revlimid’s label expansion in 1st line RRMM and as maintenance therapy in EU, Celgene (CELG) 3Q12 earnings highlighted growth of Revlimid globally on both a YoY ... data from ABRAXANE trials in melanoma and pancreatic cancer……please read our report released on 11th Nov. 2012, titled, 'ABRAXANE + Pipeline Drugs = ...
November 2012
7 pages
2013 Iraq Healthcare Sector Outlook
US$ 999.00
... long-term footprint. Opportunistic gains also exist. GOVERNMENT OF IRAQ VISION The national healthcare vision focuses heavily on the primary health care ... past five years. The public and private health care system in Iraq is one of the fastest growing in the world, and although ...
November 2012
30 pages
CIPLA– Market Perform, Great Result But Not Completely Sustainable
US$ 140.00
Q2FY13 result was ahead of our estimates largely on account of higher than ... base. On a longer term basis, we do not remain enthused about Cipla’s inhaler opportunity in Europe as it has lost the first mover advantage ... estimate by 7-8%. We upgrade our target price to Rs.360 but retain our Market Perform rating.
November 2012
9 pages
DISHMAN – Underperform, Management Accepts the Limitations of Pure Play CRAMS
US$ 140.00
... we have continuously mentioned as the biggest problem for Dishman. Management now intends enter the global generic business so ... as to utilize the idle capacity. However, the management is probably late in realizing this as it will ... and also retain our Underperform rating on Dishman with target price of Rs.47
November 2012
6 pages
Ear Care in Egypt
US$ 990.00
All ear care is categorised as Rx medicine in Egypt, with no presence for OTC products. Rx products meanwhile fall beyond the scope of this report. Euromonitor International's Ear Care in Egypt ... data. Why buy this report? Get a detailed picture of the Ear Care market; Pinpoint growth sectors and identify factors driving change ...
November 2012
16 pages
Medicated Skin Care in Egypt
US$ 990.00
... that seen at the start of the review period. Euromonitor International's Medicated Skin Care in Egypt report offers a comprehensive guide to the size and shape of the ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
November 2012
23 pages
Nuclear Medicine: Market Research Report
US$ 4,950.00
This report analyzes the worldwide markets for Nuclear Medicine in US$ Million by the following Product Segments: Gamma Cameras, and PET Scanners. The ... ., Toshiba Medical Systems Corporation, and Toshiba America Medical Systems, Inc. Market data and analytics are derived from primary and secondary research. ...
October 2012
302 pages
France Healthcare Market: 2012 Sector Report
US$ 600.00
... the government of France, the healthcare market in France will continue to grow for the years to come. The report titled “France Healthcare Sector: Sector Report” analyzes the healthcare industry of France in terms of the functioning of the healthcare ...
October 2012
40 pages
The Rise of Health Outcome Liaison Teams
US$ 645.00
... help pharma companies answer these critical questions. REPORT OVERVIEW The Rise of Health Outcome Liaison Teams At last – a practical guide to building your ... HOL strategy. This comprehensive report explains what is driving the rise of HOLs globally, and provides detailed accounts of how major pharma ...
October 2012
86 pages
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment
US$ 195.00
... examines the Causes of ADHD including Genetics Environmental and Social causes. Attention Deficit Hyperactivity Disorder ADHD is one of the more common mental ... settings including home school and in relationships with peers. If untreated the disorder can have long-term adverse effects into adolescence and ...
October 2012
95 pages
Medical Spas: A Market Analysis
US$ 995.00
This groundbreaking new analysis by Marketdata examines the growing $1.9 billion business of medical spas. There are the about 2,100 “medical spas” or “med spas” now operating in ... equipment. This study examines the med spas market structure and history, revenues/growth, key market trends and issues, effects of ...
October 2012
127 pages
Medicated Skin Care in Croatia
US$ 990.00
... within medicated skin care in Croatia during 2011 following the somewhat surprising growth recorded in average unit prices in the area during 2010. Euromonitor International's Medicated Skin Care in Croatia ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
October 2012
24 pages
Consumer Health as a Solution to the Chronic Disease Epidemic
US$ 2,000.00
... consumer health therapies in the next decade. Euromonitor International’s Consumer Health as a Solution to the Chronic Disease Epidemic global briefing examines the size, growth trends and potential opportunities in the Consumer Health market. The strategic analyses include assessing the impacts of ...
October 2012
52 pages
Medicated Skin Care in Slovenia
US$ 990.00
... treatments drove the growth of medicated skin care in Slovenia in 2011, demonstrate that at this time, demographic factors are important in medicated skin care. Euromonitor International's Medicated Skin Care in Slovenia report offers a comprehensive ... Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals ...
October 2012
32 pages
Essilor International SA in Eyewear (World)
US$ 572.00
... period. Euromonitor International’s Essilor International SA in Eyewear (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Eyewear industry. The ... data. WHY BUY THIS REPORT? Get a detailed picture of the Eyewear market; Pinpoint growth sectors and identify factors driving change ...
October 2012
34 pages
Otsuka Holdings Co Ltd in Consumer Health (World)
US$ 572.00
... one of the Asia Pacific top pharmaceutical companies, Tokyo-based Otsuka Holdings Co Ltd has developed into a top 15 company in the global consumer health ... trend of slowing sales and overreliance on mature markets. Euromonitor International’s Otsuka Holdings Co Ltd in Consumer Health (World) Company Profile offers detailed strategic analysis ...
October 2012
30 pages
2012 Healthcare Benchmarks: Health & Wellness Incentives
US$ 117.00
... a can't-miss planning tool for health and wellness program administrators, 2012 Healthcare Benchmarks: Health & Wellness Incentives is packed with actionable ... from the top three responding sectors: employers, consultants and health plans; The changing role of biometric screening — both as a tool to identify ...
September 2012
50 pages
Global Human Growth Hormone Market Report: 2012 Edition
US$ 800.00
... idiopathic. Earlier, to deal with these predicaments, growth hormone (GH) used to be extracted from the human cadavers but, as time passed and evolution of ... day. The human growth hormone market (HGH) is monopolized by a few players viz. Pfizer, NovoNordisk, Eli Lilly and Roche. The global HGH report discusses ...
September 2012
42 pages
Procter & Gamble Co,The in Consumer Health
US$ 572.00
... of the Vicks brand are already well underway, led by Teva. Euromonitor International’s Procter & Gamble Co,The in Consumer Health Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Consumer Health industry. The report ...
September 2012
34 pages
Analysis of Emerging Tumor Markers and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and emerging tumor markers, as well as extensive listings of companies, universities and research centers developing or ...
September 2012
286 pages
